Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2022 | 05-2022 | 02-2022 | 11-2021 | 08-2021 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 1 | 1,010 | -980 | -15 | -11 |
| Other Working Capital | 880 | 176 | -647 | 699 | 144 |
| Other Operating Activity | -1,938 | -1,954 | -740 | -2,300 | -1,990 |
| Operating Cash Flow | $-1,057 | $-768 | $-2,368 | $-1,616 | $-1,857 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -16 | -53 | -49 | -20 | -12 |
| Investing Cash Flow | $-16 | $-53 | $-49 | $-20 | $-12 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 150 | 3,000 | N/A | N/A | 0 |
| Other Financing Activity | -40 | 0 | 1,000 | 27 | -40 |
| Financing Cash Flow | $110 | $3,000 | $1,000 | $27 | $-40 |
| Beginning Cash Position | 2,845 | 666 | 2,083 | 3,692 | 5,602 |
| End Cash Position | 1,882 | 2,845 | 666 | 2,083 | 3,692 |
| Net Cash Flow | $-963 | $2,179 | $-1,417 | $-1,610 | $-1,909 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,057 | -768 | -2,368 | -1,616 | -1,857 |
| Capital Expenditure | -16 | -53 | -49 | -20 | -12 |
| Free Cash Flow | -1,073 | -821 | -2,417 | -1,637 | -1,869 |